Cresco Labs, Inc. (CRLBF)
0.7351
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Cresco Labs Enterprise Value : 706.27M for Aug. 27, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 27, 2026 | 706.27M |
| August 26, 2026 | 708.10M |
| August 25, 2026 | 717.41M |
| August 24, 2026 | 722.99M |
| August 21, 2026 | 737.89M |
| August 20, 2026 | 729.51M |
| August 19, 2026 | 736.43M |
| August 18, 2026 | 730.40M |
| August 17, 2026 | 726.57M |
| August 14, 2026 | 719.79M |
| August 13, 2026 | 729.67M |
| August 12, 2026 | 719.27M |
| August 11, 2026 | 722.99M |
| August 10, 2026 | 703.78M |
| August 07, 2026 | 710.11M |
| August 06, 2026 | 700.65M |
| August 05, 2026 | 677.23M |
| August 04, 2026 | 693.24M |
| August 03, 2026 | 685.72M |
| July 31, 2026 | 671.46M |
| July 30, 2026 | 683.11M |
| July 29, 2026 | 671.46M |
| July 28, 2026 | 670.01M |
| July 27, 2026 | 681.29M |
| July 24, 2026 | 685.98M |
| Date | Value |
|---|---|
| July 23, 2026 | 696.85M |
| July 22, 2026 | 697.64M |
| July 21, 2026 | 697.49M |
| July 20, 2026 | 699.53M |
| July 17, 2026 | 711.82M |
| July 16, 2026 | 708.10M |
| July 15, 2026 | 719.34M |
| July 14, 2026 | 724.15M |
| July 13, 2026 | 730.44M |
| July 10, 2026 | 715.54M |
| July 09, 2026 | 719.27M |
| July 08, 2026 | 727.09M |
| July 07, 2026 | 721.13M |
| July 06, 2026 | 719.27M |
| July 02, 2026 | 737.81M |
| July 01, 2026 | 722.99M |
| June 30, 2026 | 741.61M |
| June 29, 2026 | 732.42M |
| June 26, 2026 | 731.90M |
| June 25, 2026 | 737.43M |
| June 24, 2026 | 718.06M |
| June 23, 2026 | 717.06M |
| June 22, 2026 | 717.06M |
| June 18, 2026 | 731.90M |
| June 17, 2026 | 728.60M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| cbdMD, Inc. | 5.623M |
| Trulieve Cannabis Corp. | 2.372B |
| Tilray Brands, Inc. | 743.40M |
| ANI Pharmaceuticals, Inc. | 1.923B |
| Corcept Therapeutics, Inc. | 12.32B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 15.37M |
| Revenue (Quarterly) | 173.34M |
| Total Expenses (Quarterly) | 156.54M |
| EPS Diluted (Quarterly) | 0.0356 |
| Gross Profit Margin (Quarterly) | 46.49% |
| Profit Margin (Quarterly) | 8.87% |
| Earnings Yield | -39.67% |
| Operating Earnings Yield | 30.59% |
| Normalized Earnings Yield | -3.809 |